Native Antigen releases coronavirus antigens

By LabPulse.com staff writers

February 13, 2020 -- The Native Antigen Co. has introduced a line of coronavirus antigens from the emerging Wuhan strain, a move it said will support research and the development of diagnostics and vaccines.

The antigens were derived from the novel coronavirus (2019-nCoV) using the company's proprietary VirtuE expression system. The system introduces proper protein folding and post-translational modifications to recombinant proteins, which are essential for full biological and antigenic activity, according to the company.


Copyright © 2020 LabPulse.com
 

To read this and get access to all of the exclusive content on LabPulse.com, create a free account or sign in now.

Member Sign In:
MemberID or email address:  
Do you have a LabPulse.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?